Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of opioid-induced pruritus after spinal anesthesia in femoral fracture surgery
IRCT20141209020258N141Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ondansetron, propofol, dexamethasone and midazolam in opioid-induced pruritus (OIP) (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Itching and Sedation. Started Feb 2020; status: completed.
02
Drugs
ondansetronpropofoldexamethasonemidazolam
03
Conditions
opioid-induced pruritus (OIP)
Beyond the preview
Go deeper on IRCT20141209020258N141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N141.